img

Global Lisdexamfetamine Industry Research Report, Growth Trends and Competitive Analysis 2024-2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Lisdexamfetamine Industry Research Report, Growth Trends and Competitive Analysis 2024-2034

Lisdexamfetamine (contracted from L-lysine-dextroamphetamine) is a substituted amphetamine and an inactive prodrug of the central nervous system (CNS) stimulant dextroamphetamine that is used in the treatment of attention deficit hyperactivity disorder (ADHD) and binge eating disorder.
Due to the COVID-19 pandemic, the global Lisdexamfetamine market size was US$ million in 2022 and is forecast to a readjusted size of US$ million by 2034 with a CAGR of % during the forecast period 2024-2034. Fully considering the economic change by this health crisis, Capsule accounting for % of the Lisdexamfetamine global market in 2022, is projected to value US$ million by 2034, growing at a revised % CAGR from 2024 to 2034. While ADHD in Adults segment is altered to an % CAGR throughout this forecast period.
The global key companies of Lisdexamfetamine include Takeda. etc. In 2022, the global top five players had a share approximately % in terms of revenue.
The United States Lisdexamfetamine market size was US$ million in 2022, while China size was US$ million. The proportion of the United States was % in 2022, while China percentage was %, and it is predicted that China share will reach % in 2034, trailing a CAGR of % through the analysis period. As for the Europe Lisdexamfetamine landscape, Germany is projected to reach US$ million by 2034. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
The market research report offered here is a very useful resource that can help manufacturers, stakeholders, decision-makers, and other market participants to become familiar with every factor impacting the growth of the global Lisdexamfetamine market. The analysts authoring the report have closely studied key strategies adopted by top players of the global Lisdexamfetamine market. The report includes SWOT, and other market analyses to provide a clear and deep understanding of important aspects of the global Lisdexamfetamine market. Readers of the report can become informed about current and future trends of the global Lisdexamfetamine market and how they will impact market growth during the forecast period.



By Company


Takeda
Segment by Type
Capsule
Chewable Tablet

Segment by Application


ADHD in Adults
ADHD in Children
B.E.D. in Adults
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E

Chapter Outline


Chapter 1Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on.
Chapter 2Revenue of Lisdexamfetamine in global and regional level.
Chapter 3Detailed analysis of Lisdexamfetamine companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 7Europe by type, by application and by country, revenue for each segment.
Chapter 8Asia Pacific by type, by application and by region, revenue for each segment.
Chapter 9Latin America by type, by application and by country, revenue for each segment.
Chapter 10Middle East and Africa, by type, by application and by country, revenue for each segment.
Chapter 11Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Lisdexamfetamine revenue, gross margin, and recent development, etc.
Chapter 12Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 13Research Findings and Conclusion

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Lisdexamfetamine Market Size Growth Rate by Type: 2018 VS 2022 VS 2034
1.2.2 Capsule
1.2.3 Chewable Tablet
1.3 Market by Application
1.3.1 Global Lisdexamfetamine Market Growth Rate by Application: 2018 VS 2022 VS 2034
1.3.2 ADHD in Adults
1.3.3 ADHD in Children
1.3.4 B.E.D. in Adults
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Market Perspective
2.1 Global Lisdexamfetamine Market Size (2018-2034)
2.2 Lisdexamfetamine Market Size across Key Geographies Worldwide: 2018 VS 2022 VS 2034
2.3 Global Lisdexamfetamine Market Size by Region (2018-2024)
2.4 Global Lisdexamfetamine Market Size Forecast by Region (2024-2034)
2.5 Global Top 10 Lisdexamfetamine Countries Ranking by Market Size
3 Lisdexamfetamine Competitive by Company
3.1 Global Lisdexamfetamine Revenue by Players
3.1.1 Global Lisdexamfetamine Revenue by Players (2018-2024)
3.1.2 Global Lisdexamfetamine Market Share by Players (2018-2024)
3.2 Global Lisdexamfetamine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Company Covered: Ranking by Lisdexamfetamine Revenue
3.4 Global Lisdexamfetamine Market Concentration Ratio
3.4.1 Global Lisdexamfetamine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Lisdexamfetamine Revenue in 2022
3.5 Global Key Players of Lisdexamfetamine Head office and Area Served
3.6 Global Key Players of Lisdexamfetamine, Product and Application
3.7 Global Key Players of Lisdexamfetamine, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Global Lisdexamfetamine Breakdown Data by Type
4.1 Global Lisdexamfetamine Historic Revenue by Type (2018-2024)
4.2 Global Lisdexamfetamine Forecasted Revenue by Type (2024-2034)
5 Global Lisdexamfetamine Breakdown Data by Application
5.1 Global Lisdexamfetamine Historic Market Size by Application (2018-2024)
5.2 Global Lisdexamfetamine Forecasted Market Size by Application (2024-2034)
6 North America
6.1 North America Lisdexamfetamine Revenue by Company (2021-2024)
6.2 North America Lisdexamfetamine Revenue by Type (2018-2034)
6.3 North America Lisdexamfetamine Revenue by Application (2018-2034)
6.4 North America Lisdexamfetamine Revenue by Country (2018-2034)
6.4.1 U.S.
6.4.2 Canada
7 Europe
7.1 Europe Lisdexamfetamine Revenue by Company (2021-2024)
7.2 Europe Lisdexamfetamine Revenue by Type (2018-2034)
7.3 Europe Lisdexamfetamine Revenue by Application (2018-2034)
7.4 Europe Lisdexamfetamine Revenue by Country (2018-2034)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
8 Asia Pacific
8.1 Asia Pacific Lisdexamfetamine Revenue by Company (2021-2024)
8.2 Asia Pacific Lisdexamfetamine Revenue by Type (2018-2034)
8.3 Asia Pacific Lisdexamfetamine Revenue by Application (2018-2034)
8.4 Asia Pacific Lisdexamfetamine Revenue by Region (2018-2034)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 India
8.4.5 Australia
8.4.6 Taiwan
8.4.7 Indonesia
8.4.8 Thailand
8.4.9 Malaysia
8.4.10 Philippines
8.4.11 Vietnam
9 Latin America
9.1 Latin America Lisdexamfetamine Revenue by Company (2021-2024)
9.2 Latin America Lisdexamfetamine Revenue by Type (2018-2034)
9.3 Latin America Lisdexamfetamine Revenue by Application (2018-2034)
9.4 Latin America Lisdexamfetamine Revenue by Country (2018-2034)
9.4.1 Mexico
9.4.2 Brazil
9.4.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Lisdexamfetamine Revenue by Company (2021-2024)
10.2 Middle East and Africa Lisdexamfetamine Revenue by Type (2018-2034)
10.3 Middle East and Africa Lisdexamfetamine Revenue by Application (2018-2034)
10.4 Middle East and Africa Lisdexamfetamine Revenue by Country (2018-2034)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 U.A.E
11 Company Profiles
11.1 Takeda
11.1.1 Takeda Company Details
11.1.2 Takeda Business Overview
11.1.3 Takeda Lisdexamfetamine Products and Services
11.1.4 Takeda Lisdexamfetamine Revenue in Lisdexamfetamine Business (2018-2024)
11.1.5 Takeda Lisdexamfetamine SWOT Analysis
11.1.6 Takeda Recent Development
12 Lisdexamfetamine Market Dynamics
12.1 Lisdexamfetamine Industry Trends
12.2 Lisdexamfetamine Market Drivers
12.3 Lisdexamfetamine Market Challenges
12.4 Lisdexamfetamine Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details

List of Figure

List of Tables
Table 1. Global Lisdexamfetamine Market Size Growth Rate (CAGR) by Type (US$ Million), 2018 VS 2022 VS 2034
Table 2. Key Players of Capsule
Table 3. Key Players of Chewable Tablet
Table 4. Global Lisdexamfetamine Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2034
Table 5. Global Lisdexamfetamine Market Size (US$ Million) Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
Table 6. Global Lisdexamfetamine Revenue by Region (2018-2024) & (US$ Million)
Table 7. Global Lisdexamfetamine Revenue Forecast by Region (2024-2034) & (US$ Million)
Table 8. Global Lisdexamfetamine Market Size of Top 10 Countries, 2018 VS 2022 VS 2034, (US$ Million)
Table 9. Global Lisdexamfetamine Revenue by Players (2018-2024) & (US$ Million)
Table 10. Global Lisdexamfetamine Market Share by Players (2018-2024)
Table 11. Global Top Lisdexamfetamine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lisdexamfetamine as of 2022)
Table 12. Ranking of Global Top Lisdexamfetamine Companies by Revenue (US$ Million) in 2022
Table 13. Global 5 Largest Players Market Share by Lisdexamfetamine Revenue (CR5 and HHI) & (2018-2024)
Table 14. Global Key Players of Lisdexamfetamine, Headquarters and Area Served
Table 15. Global Key Players of Lisdexamfetamine, Product and Application
Table 16. Global Key Players of Lisdexamfetamine, Date of Enter into This Industry
Table 17. Mergers & Acquisitions, Expansion Plans
Table 18. Global Lisdexamfetamine Market Size by Type (2018-2024) & (US$ Million)
Table 19. Global Lisdexamfetamine Revenue Market Share by Type (2018-2024)
Table 20. Global Lisdexamfetamine Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 21. Global Lisdexamfetamine Revenue Market Share by Type (2024-2034)
Table 22. Global Lisdexamfetamine Market Size by Application (2018-2024) & (US$ Million)
Table 23. Global Lisdexamfetamine Revenue Market Share by Application (2018-2024)
Table 24. Global Lisdexamfetamine Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 25. Global Lisdexamfetamine Revenue Market Share by Application (2024-2034)
Table 26. North America Lisdexamfetamine Revenue by Company (2021-2024) & (US$ Million)
Table 27. North America Lisdexamfetamine Revenue by Type (2018-2024) & (US$ Million)
Table 28. North America Lisdexamfetamine Revenue by Type (2024-2034) & (US$ Million)
Table 29. North America Lisdexamfetamine Revenue by Application (2018-2024) & (US$ Million)
Table 30. North America Lisdexamfetamine Revenue by Application (2024-2034) & (US$ Million)
Table 31. North America Lisdexamfetamine Revenue Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2034
Table 32. North America Lisdexamfetamine Revenue by Country (2018-2024) & (US$ Million)
Table 33. North America Lisdexamfetamine Revenue by Country (2024-2034) & (US$ Million)
Table 34. Europe Lisdexamfetamine Revenue by Company (2021-2024) & (US$ Million)
Table 35. Europe Lisdexamfetamine Revenue by Type (2018-2024) & (US$ Million)
Table 36. Europe Lisdexamfetamine Revenue by Type (2024-2034) & (US$ Million)
Table 37. Europe Lisdexamfetamine Revenue by Application (2018-2024) & (US$ Million)
Table 38. Europe Lisdexamfetamine Revenue by Application (2024-2034) & (US$ Million)
Table 39. Europe Lisdexamfetamine Revenue Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2034
Table 40. Europe Lisdexamfetamine Revenue by Country (2018-2024) & (US$ Million)
Table 41. Europe Lisdexamfetamine Revenue by Country (2024-2034) & (US$ Million)
Table 42. Asia Pacific Lisdexamfetamine Revenue by Company (2021-2024) & (US$ Million)
Table 43. Asia Pacific Lisdexamfetamine Revenue by Type (2018-2024) & (US$ Million)
Table 44. Asia Pacific Lisdexamfetamine Revenue by Type (2024-2034) & (US$ Million)
Table 45. Asia Pacific Lisdexamfetamine Revenue by Application (2018-2024) & (US$ Million)
Table 46. Asia Pacific Lisdexamfetamine Revenue by Application (2024-2034) & (US$ Million)
Table 47. Asia-Pacific Lisdexamfetamine Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2034
Table 48. Asia Pacific Lisdexamfetamine Revenue by Region (2018-2024) & (US$ Million)
Table 49. Asia Pacific Lisdexamfetamine Revenue by Region (2024-2034) & (US$ Million)
Table 50. Latin America Lisdexamfetamine Revenue by Company (2021-2024) & (US$ Million)
Table 51. Latin America Lisdexamfetamine Revenue by Type (2018-2024) & (US$ Million)
Table 52. Latin America Lisdexamfetamine Revenue by Type (2024-2034) & (US$ Million)
Table 53. Latin America Lisdexamfetamine Revenue by Application (2018-2024) & (US$ Million)
Table 54. Latin America Lisdexamfetamine Revenue by Application (2024-2034) & (US$ Million)
Table 55. Latin America Lisdexamfetamine Revenue Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2034
Table 56. Latin America Lisdexamfetamine Revenue by Country (2018-2024) & (US$ Million)
Table 57. Latin America Lisdexamfetamine Revenue by Country (2024-2034) & (US$ Million)
Table 58. Middle East and Africa Lisdexamfetamine Revenue by Company (2021-2024) & (US$ Million)
Table 59. Middle East and Africa Lisdexamfetamine Revenue by Type (2018-2024) & (US$ Million)
Table 60. Middle East and Africa Lisdexamfetamine Revenue by Type (2024-2034) & (US$ Million)
Table 61. Middle East and Africa Lisdexamfetamine Revenue by Application (2018-2024) & (US$ Million)
Table 62. Middle East and Africa Lisdexamfetamine Revenue by Application (2024-2034) & (US$ Million)
Table 63. Middle East and Africa Lisdexamfetamine Revenue Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2034
Table 64. Middle East and Africa Lisdexamfetamine Revenue by Country (2018-2024) & (US$ Million)
Table 65. Middle East and Africa Lisdexamfetamine Revenue by Country (2024-2034) & (US$ Million)
Table 66. Takeda Company Details
Table 67. Takeda Business Overview
Table 68. Takeda Lisdexamfetamine Product and Services
Table 69. Takeda Lisdexamfetamine Revenue in Lisdexamfetamine Business (2018-2024) & (US$ Million)
Table 70. Takeda Lisdexamfetamine SWOT Analysis
Table 71. Takeda Recent Development
Table 72. Lisdexamfetamine Market Trends
Table 73. Lisdexamfetamine Market Drivers
Table 74. Lisdexamfetamine Market Challenges
Table 75. Lisdexamfetamine Market Restraints
Table 76. Research Programs/Design for This Report
Table 77. Key Data Information from Secondary Sources
Table 78. Key Data Information from Primary Sources
List of Figures
Figure 1. Lisdexamfetamine Product Picture
Figure 2. Global Lisdexamfetamine Market Size by Type (US$ Million): 2018 VS 2022 VS 2034
Figure 3. Global Lisdexamfetamine Market Share by Type: 2022 VS 2034
Figure 4. Capsule Features
Figure 5. Chewable Tablet Features
Figure 6. Global Lisdexamfetamine Market Size by Application (US$ Million): 2018 VS 2022 VS 2034
Figure 7. Global Lisdexamfetamine Market Share by Application: 2022 VS 2034
Figure 8. ADHD in Adults
Figure 9. ADHD in Children
Figure 10. B.E.D. in Adults
Figure 11. Lisdexamfetamine Report Years Considered
Figure 12. Global Lisdexamfetamine Revenue, (US$ Million), 2018 VS 2022 VS 2034
Figure 13. Global Lisdexamfetamine Market Size 2018-2034 (US$ Million)
Figure 14. Global Lisdexamfetamine Market Size Market Share by Region: 2022 VS 2034
Figure 15. Global Lisdexamfetamine Revenue Market Share by Region in 2018 VS 2022
Figure 16. Global Lisdexamfetamine Revenue Market Share Forecast by Region (2024-2034)
Figure 17. Global Top 10 Lisdexamfetamine Countries Ranking by Market Size (US$ Million) in 2022
Figure 18. Global Lisdexamfetamine Market Size of Top 10 Countries, 2018 VS 2022 VS 2034, (US$ Million)
Figure 19. Global Lisdexamfetamine Market Share by Players in 2022
Figure 20. Global Top Lisdexamfetamine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lisdexamfetamine as of 2022)
Figure 21. The Top 10 and 5 Players Market Share by Lisdexamfetamine Revenue in 2022
Figure 22. North America Lisdexamfetamine Revenue Market Share by Company in 2022
Figure 23. North America Lisdexamfetamine Revenue Market Share by Type (2018-2034)
Figure 24. North America Lisdexamfetamine Revenue Market Share by Application (2018-2034)
Figure 25. North America Lisdexamfetamine Revenue Share by Country (2018-2034)
Figure 26. U.S. Lisdexamfetamine Revenue (2018-2034) & (US$ Million)
Figure 27. Canada Lisdexamfetamine Revenue (2018-2034) & (US$ Million)
Figure 28. Europe Lisdexamfetamine Revenue Market Share by Company in 2022
Figure 29. Europe Lisdexamfetamine Revenue Market Share by Type (2018-2034)
Figure 30. Europe Lisdexamfetamine Revenue Market Share by Application (2018-2034)
Figure 31. Europe Lisdexamfetamine Revenue Share by Country (2018-2034)
Figure 32. Germany Lisdexamfetamine Revenue (2018-2034) & (US$ Million)
Figure 33. France Lisdexamfetamine Revenue (2018-2034) & (US$ Million)
Figure 34. U.K. Lisdexamfetamine Revenue (2018-2034) & (US$ Million)
Figure 35. Italy Lisdexamfetamine Revenue (2018-2034) & (US$ Million)
Figure 36. Russia Lisdexamfetamine Revenue (2018-2034) & (US$ Million)
Figure 37. Asia Pacific Lisdexamfetamine Revenue Market Share by Company in 2022
Figure 38. Asia Pacific Lisdexamfetamine Revenue Market Share by Type (2018-2034)
Figure 39. Asia Pacific Lisdexamfetamine Revenue Market Share by Application (2018-2034)
Figure 40. Asia Pacific Lisdexamfetamine Revenue Share by Region (2018-2034)
Figure 41. China Lisdexamfetamine Revenue (2018-2034) & (US$ Million)
Figure 42. Japan Lisdexamfetamine Revenue (2018-2034) & (US$ Million)
Figure 43. South Korea Lisdexamfetamine Revenue (2018-2034) & (US$ Million)
Figure 44. India Lisdexamfetamine Revenue (2018-2034) & (US$ Million)
Figure 45. Australia Lisdexamfetamine Revenue (2018-2034) & (US$ Million)
Figure 46. Taiwan Lisdexamfetamine Revenue (2018-2034) & (US$ Million)
Figure 47. Indonesia Lisdexamfetamine Revenue (2018-2034) & (US$ Million)
Figure 48. Thailand Lisdexamfetamine Revenue (2018-2034) & (US$ Million)
Figure 49. Malaysia Lisdexamfetamine Revenue (2018-2034) & (US$ Million)
Figure 50. Philippines Lisdexamfetamine Revenue (2018-2034) & (US$ Million)
Figure 51. Vietnam Lisdexamfetamine Revenue (2018-2034) & (US$ Million)
Figure 52. Latin America Lisdexamfetamine Revenue Market Share by Company in 2022
Figure 53. Latin America Lisdexamfetamine Revenue Market Share by Type (2018-2034)
Figure 54. Latin America Lisdexamfetamine Revenue Market Share by Application (2018-2034)
Figure 55. Latin America Lisdexamfetamine Revenue Share by Country (2018-2034)
Figure 56. Mexico Lisdexamfetamine Revenue (2018-2034) & (US$ Million)
Figure 57. Brazil Lisdexamfetamine Revenue (2018-2034) & (US$ Million)
Figure 58. Argentina Lisdexamfetamine Revenue (2018-2034) & (US$ Million)
Figure 59. Middle East and Africa Lisdexamfetamine Revenue Market Share by Company in 2022
Figure 60. Middle East and Africa Lisdexamfetamine Revenue Market Share by Type (2018-2034)
Figure 61. Middle East and Africa Lisdexamfetamine Revenue Market Share by Application (2018-2034)
Figure 62. Middle East and Africa Lisdexamfetamine Revenue Share by Country (2018-2034)
Figure 63. Turkey Lisdexamfetamine Revenue (2018-2034) & (US$ Million)
Figure 64. Saudi Arabia Lisdexamfetamine Revenue (2018-2034) & (US$ Million)
Figure 65. U.A.E Lisdexamfetamine Revenue (2018-2034) & (US$ Million)
Figure 66. Takeda Revenue Growth Rate in Lisdexamfetamine Business (2018-2024)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed